$XCUR
Exicure Inc

2022 Q3 Form 10-Q Financial Statement

#000169853022000058 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $2.016M $2.471M $2.565M
YoY Change -154.83% 3027.85% 157.27%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.416M $3.205M $3.162M
YoY Change -18.02% 3.45% 9.41%
% of Gross Profit
Research & Development $4.805M $6.749M $7.140M
YoY Change -70.8% -37.76% -30.42%
% of Gross Profit
Depreciation & Amortization $289.0K $291.0K $302.0K
YoY Change 2.12% 1.75% 16.15%
% of Gross Profit
Operating Expenses $7.221M $9.954M $10.30M
YoY Change -62.79% -28.6% -21.68%
Operating Profit -$5.205M -$7.483M -$7.737M
YoY Change -77.45% -46.02% -36.36%
Interest Expense $0.00 $0.00 $595.0K
YoY Change -100.0% -100.0% 45.48%
% of Operating Profit
Other Income/Expense, Net $45.00K $13.00K -$611.0K
YoY Change -110.0% -103.19% 90.94%
Pretax Income -$5.160M -$7.470M -$8.348M
YoY Change -78.07% -47.65% -33.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.160M -$7.470M -$8.348M
YoY Change -78.07% -47.65% -33.09%
Net Earnings / Revenue -255.95% -302.31% -325.46%
Basic Earnings Per Share -$1.04 -$1.66 -$0.07
Diluted Earnings Per Share -$1.04 -$1.66 -$0.07
COMMON SHARES
Basic Shares Outstanding 4.963M shares 4.504M shares 120.9M shares
Diluted Shares Outstanding 4.963M shares 4.504M shares 120.9M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.65M $22.20M $26.38M
YoY Change -74.28% -60.41% -60.85%
Cash & Equivalents $15.65M $21.20M $23.89M
Short-Term Investments $0.00 $997.0K $2.494M
Other Short-Term Assets $1.552M $2.526M $2.798M
YoY Change -52.71% -44.41% -55.59%
Inventory
Prepaid Expenses $501.0K $1.059M $1.175M
Receivables
Other Receivables
Total Short-Term Assets $17.20M $24.72M $29.18M
YoY Change -73.19% -59.24% -60.56%
LONG-TERM ASSETS
Property, Plant & Equipment $3.032M $3.325M $3.612M
YoY Change -27.31% -18.94% -11.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.277M $1.300M $1.321M
YoY Change -12.83% -9.53% -7.36%
Total Long-Term Assets $11.74M $12.23M $12.71M
YoY Change -14.61% -11.48% -8.93%
TOTAL ASSETS
Total Short-Term Assets $17.20M $24.72M $29.18M
Total Long-Term Assets $11.74M $12.23M $12.71M
Total Assets $28.94M $36.96M $41.90M
YoY Change -62.85% -50.37% -52.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $920.0K $1.593M $1.918M
YoY Change -62.98% -29.2% -35.55%
Accrued Expenses $3.016M $3.308M $3.227M
YoY Change -44.96% 2.48% 32.2%
Deferred Revenue $21.77M $14.76M $16.22M
YoY Change 55.36% 103.04% 120.75%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change
Total Short-Term Liabilities $25.71M $19.66M $21.36M
YoY Change 16.97% 54.23% 67.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.71M $19.66M $21.36M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $32.65M $35.79M $38.66M
YoY Change -48.93% -5.38% 1.99%
SHAREHOLDERS EQUITY
Retained Earnings -$191.0M -$185.9M -$178.4M
YoY Change 22.28% 40.07% 50.63%
Common Stock $0.00 $0.00 $12.00K
YoY Change -100.0% -100.0% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.703M $1.163M $3.236M
YoY Change
Total Liabilities & Shareholders Equity $28.94M $36.96M $41.90M
YoY Change -62.85% -50.37% -52.36%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.160M -$7.470M -$8.348M
YoY Change -78.07% -47.65% -33.09%
Depreciation, Depletion And Amortization $289.0K $291.0K $302.0K
YoY Change 2.12% 1.75% 16.15%
Cash From Operating Activities -$6.548M -$9.078M -$12.76M
YoY Change -234.65% -18.03% -13.86%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.000K $6.000K
YoY Change -100.0% -98.8% -97.33%
Acquisitions
YoY Change
Other Investing Activities $998.0K $1.500M $2.001M
YoY Change -77.84% -92.34% -87.11%
Cash From Investing Activities $998.0K $1.496M $1.995M
YoY Change -77.54% -92.22% -86.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $7.500M
YoY Change
Cash From Financing Activities -2.000K 4.890M -$7.993M
YoY Change -77.78% 3750.39% -1563.92%
NET CHANGE
Cash From Operating Activities -6.548M -9.078M -$12.76M
Cash From Investing Activities 998.0K 1.496M $1.995M
Cash From Financing Activities -2.000K 4.890M -$7.993M
Net Change In Cash -5.552M -2.692M -$18.75M
YoY Change -159.71% -132.49% -1913.73%
FREE CASH FLOW
Cash From Operating Activities -$6.548M -$9.078M -$12.76M
Capital Expenditures $0.00 -$4.000K $6.000K
Free Cash Flow -$6.548M -$9.074M -$12.76M
YoY Change -233.04% -15.52% -15.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
673-1700
dei City Area Code
CityAreaCode
(847)
dei Entity Central Index Key
EntityCentralIndexKey
0001698530
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39011
dei Entity Registrant Name
EntityRegistrantName
EXICURE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5333008
dei Entity Address Address Line1
EntityAddressAddressLine1
2430 N. Halsted St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60614
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
XCUR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4962583 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21198000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34644000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
997000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
4497000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2526000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4525000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
24721000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
43666000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3325000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3927000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7609000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7950000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1300000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9325000 usd
CY2022Q2 us-gaap Assets
Assets
36955000 usd
CY2021Q4 us-gaap Assets
Assets
64868000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6873000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1593000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3413000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3308000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6464000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14755000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17317000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
19656000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34067000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9035000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11509000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7101000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7404000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
656000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
35792000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
53636000 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4962231 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4962231 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3626073 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3626073 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
187053000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181301000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185885000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170067000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1163000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11232000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36955000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64868000 usd
CY2022Q2 xcur Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
2471000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 xcur Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
79000 usd
xcur Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
5036000 usd
xcur Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
1076000 usd
CY2022Q2 us-gaap Revenues
Revenues
2471000 usd
CY2021Q2 us-gaap Revenues
Revenues
79000 usd
us-gaap Revenues
Revenues
5036000 usd
us-gaap Revenues
Revenues
1076000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6749000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10843000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13889000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21105000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3205000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3098000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6367000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5990000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
9954000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
13941000 usd
us-gaap Operating Expenses
OperatingExpenses
20256000 usd
us-gaap Operating Expenses
OperatingExpenses
27095000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7483000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13862000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15220000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-26019000 usd
CY2022Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
16000 usd
CY2021Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
18000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
3000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
43000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
131000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
0 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
450000 usd
us-gaap Interest Expense
InterestExpense
595000 usd
us-gaap Interest Expense
InterestExpense
859000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-407000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-598000 usd
CY2021Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
283000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-727000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7470000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14269000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15818000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26746000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4962231 shares
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7470000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14269000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15818000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26746000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.12
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4503983 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4503983 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2934770 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2934770 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4268955 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4268955 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2931607 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2931607 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7470000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14269000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15818000 usd
CY2022Q2 xcur Retained Earnings Accumulated Deficit Inceptionto Date
RetainedEarningsAccumulatedDeficitInceptiontoDate
-204722000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26746000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4962231 shares
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-78000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-78000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7470000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14296000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15821000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26824000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11232000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
342000 usd
CY2022Q1 xcur Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
14000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8348000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3626073 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3236000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
507000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4886000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7470000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1163000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61506000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
546000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
517000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12477000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
50041000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
764000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
131000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14269000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
36640000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15818000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26746000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
593000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
546000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
849000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1281000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
477000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
141000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
341000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
325000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-171000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
18000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
6000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1999000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
357000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-24000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
44000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1820000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
415000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3156000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-280000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5036000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1076000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-303000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-263000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21834000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25885000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1499000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2000000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
5000000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
37097000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
564000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3491000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34533000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7500000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
506000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5054000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
154000 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
131000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
546000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3103000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
677000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21446000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9325000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43844000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34462000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22398000 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3626073 shares
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43787000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21198000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34644000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1200000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9200000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22398000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43844000 usd
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
30000 sqft
CY2022Q2 xcur Cash Cash Equivalents Short Term Investments And Restricted Cash
CashCashEquivalentsShortTermInvestmentsAndRestrictedCash
23395000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23790000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstances and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.</span></div>
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28826000 usd
xcur Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
5036000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1059000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2484000 usd
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
268000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
763000 usd
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1199000 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1278000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2526000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4525000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1200000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9200000 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
100000 usd
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
125000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1300000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9325000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6578000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6594000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3253000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2667000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3325000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3927000 usd
CY2022Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
291000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
593000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
546000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
326000 usd
CY2022Q2 xcur Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
1446000 usd
CY2021Q4 xcur Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
3689000 usd
CY2022Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
391000 usd
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1191000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
496000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
459000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
975000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1125000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3308000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6464000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
326000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
652000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
653000 usd
xcur Debt Securities Available For Sale Current Percent
DebtSecuritiesAvailableForSaleCurrentPercent
1
xcur Debt Securities Available For Sale Noncurrent Percent
DebtSecuritiesAvailableForSaleNoncurrentPercent
0
xcur Debt Securities Availablefor Sale Percent
DebtSecuritiesAvailableforSalePercent
1
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
505000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
195000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
846000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
572000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
31000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
62000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
832000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
552000 usd
us-gaap Lease Cost
LeaseCost
1513000 usd
us-gaap Lease Cost
LeaseCost
1287000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1703000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1106000 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
391000 usd
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
1191000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
832000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
32000 usd
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
391000 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 xcur Common Stock Voting Rights For Each Share
CommonStockVotingRightsForEachShare
1 vote
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
576261 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.1031
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-3000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 usd
CY2022Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
0 usd
CY2022Q2 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2021Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-51000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51000 usd
CY2021Q2 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-27000 usd
CY2021Q2 us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0356
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
507000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
764000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
849000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1281000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2850000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0286
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0036
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0112
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.952
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.958
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.952
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.817
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.836
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.826
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.30
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
331420 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.82
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
232028 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
124 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
246062 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
63.45
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
317262 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
165378 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
33.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
304522 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
20.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2022Q2 xcur Stock Option Exercise Price
StockOptionExercisePrice
5.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
77000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
CY2022Q2 xcur Stock Option Exercise Price
StockOptionExercisePrice
5.51
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
233224 shares
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7470000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14269000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15818000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26746000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4503983 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4503983 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2934770 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2934770 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4268955 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4268955 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2931607 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2931607 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.12
CY2022Q1 xcur Loss Contingency Number Of Plaintiffs Requesting Appointment As Lead Plaintiff
LossContingencyNumberOfPlaintiffsRequestingAppointmentAsLeadPlaintiff
4 plaintiff
CY2022Q1 xcur Loss Contingency Number Of Plaintiffs That Withdrew Request For Appointment As Lead Plaintiff
LossContingencyNumberOfPlaintiffsThatWithdrewRequestForAppointmentAsLeadPlaintiff
2 plaintiff
CY2022Q1 xcur Loss Contingency Number Of Plaintiffs Requesting Appointment As Lead Plaintiff
LossContingencyNumberOfPlaintiffsRequestingAppointmentAsLeadPlaintiff
2 plaintiff
CY2022Q2 xcur Aggregate Payments Made To Date For License Agreements
AggregatePaymentsMadeToDateForLicenseAgreements
11438000 usd

Files In Submission

Name View Source Status
0001698530-22-000058-index-headers.html Edgar Link pending
0001698530-22-000058-index.html Edgar Link pending
0001698530-22-000058.txt Edgar Link pending
0001698530-22-000058-xbrl.zip Edgar Link pending
ex103_exicure-formofrsuagr.htm Edgar Link pending
exicureexhibit311-63022.htm Edgar Link pending
exicureexhibit312-63022.htm Edgar Link pending
exicureexhibit321-63022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xcur-20220630.htm Edgar Link pending
xcur-20220630.xsd Edgar Link pending
xcur-20220630_g1.jpg Edgar Link pending
xcur-20220630_def.xml Edgar Link unprocessable
xcur-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
xcur-20220630_lab.xml Edgar Link unprocessable
xcur-20220630_cal.xml Edgar Link unprocessable
xcur-20220630_htm.xml Edgar Link completed